Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis
The FASEB Journal · 2023
DOI: 10.1096/fj.202201777rrr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Hiroyuki Kadoya und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan. Hauptthemen laut MEDLINE: Peritoneal Fibrosis, Peritonitis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Kawasaki Medical School.
Abstract (Originalsprache)
During peritoneal dialysis (PD), the peritoneum is exposed to a bioincompatible dialysate, deteriorating the tissue and limiting the long‐term effectiveness of PD. Peritoneal fibrosis is triggered by chronic inflammation induced by a variety of stimuli, including peritonitis. Exposure to PD fluid alters peritoneal macrophages phenotype. Inflammasome activation triggers chronic inflammation. First, it was determined whether inflammasome activation causes peritoneal deterioration. In the in vivo experiments, the increased expression of the inflammasome components, caspase‐1 activity, and concomitant overproduction of IL‐1β and IL‐18 were observed in a mouse model of peritoneal fibrosis. ASC‐positive and F4/80‐positive cells colocalized in the subperitoneal mesothelial cell layer. These macrophages expressed high CD44 levels indicating that the CD44‐positive macrophages contribute to developing peritoneal deterioration. Furthermore, intravital imaging of the peritoneal microvasculature demonstrated that the circulating CD44‐positive leukocytes may contribute to peritoneal fibrosis. Bone marrow transplantation in ASC‐deficient mice suppressed inflammasome activation, thereby attenuating peritoneal fibrosis in a high glucose‐based PD solution‐injected mouse model. Our results suggest inflammasome activation in CD44‐positive macrophages may be involved in developing peritoneal fibrosis. The inflammasome‐derived pro‐inflammatory cytokines might therefore serve as new biomarkers for developing encapsulating peritoneal sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.
- Advanced Cancer Medicine for Gynecologic Cancer, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
ORCID-Profile: Hiroyuki Kadoya, Kengo Kidokoro, Seiji Kishi, Hajime Nagasu, Tamaki Sasaki, Masafumi Takahashi, Naoki Kashihara
Förderung
- Japan Society for the Promotion of Science
- Kawasaki Medical School
Zitieren
APA
Kadoya, H., Hirano, A., Umeno, R., Kajimoto, E., Iwakura, T., Kondo, M., Wada, Y., Kidokoro, K., Kishi, S., Nagasu, H., Sasaki, T., Taniguchi, S., Takahashi, M., & Kashihara, N. (2023). Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202201777rrr
Vancouver
Kadoya H, Hirano A, Umeno R, Kajimoto E, Iwakura T, Kondo M, et al. Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis. The FASEB Journal. 2023. doi:10.1096/fj.202201777rrr
BibTeX
@article{Kadoya2023,
author = {Kadoya, Hiroyuki and Hirano, Akira and Umeno, Reina and Kajimoto, Eriko and Iwakura, Tsukasa and Kondo, Megumi and Wada, Yoshihisa and Kidokoro, Kengo and Kishi, Seiji and Nagasu, Hajime and Sasaki, Tamaki and Taniguchi, Shun'ichiro and Takahashi, Masafumi and Kashihara, Naoki},
title = {Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202201777rrr}
}
EUVIMED